Het Catharina Ziekenhuis is het grootste algemeen ziekenhuis van Eindhoven. Het is gevestigd aan de Michelangelolaan te Woensel. Het Catharina Ziekenhuis is een topklinisch en topreferent opleidingsziekenhuis.

During the past decade, Catharina Ziekenhuis conducted 237 clinical trials. In the 10-year time frame, 237 clinical trials started and 61 clinical trials were completed, i.e. on average, 25.7% percent of trials that started reached the finish line to date. In the past 5 years, 117 clinical trials started and 32 clinical trials were completed. i.e. 27.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Catharina Ziekenhuis" #1 sponsor was "Catharina Ziekenhuis Eindhoven" with 56 trials, followed by "Radboud University Medical Center" with 21 trials sponsored, "Maastricht University Medical Center" with 20 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 14 trials sponsored and "The Netherlands Cancer Institute" with 14 trials sponsored. Other sponsors include 271 different institutions and companies that sponsored additional 136 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Catharina Ziekenhuis" #1 collaborator was "Catharina Ziekenhuis Eindhoven" with 29 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 27 trials as a collaborator, "Dutch Cancer Society" with 18 trials as a collaborator, "Erasmus Medical Center" with 17 trials as a collaborator and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 10 trials as a collaborator. Other collaborators include 406 different institutions and companies that were collaborators in the rest 283 trials.

According to Clinical.Site data, the most researched conditions in "Catharina Ziekenhuis" are "Coronary Artery Disease" (28 trials), "Atrial Fibrillation" (18 trials), "Heart Failure" (13 trials), "Breast Cancer" (12 trials) and "Prostate Cancer" (12 trials). Many other conditions were trialed in "Catharina Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Catharina Ziekenhuis" are "Drug" (143 trials), "Device" (100 trials), "Procedure" (66 trials), "Other" (51 trials) and "Radiation" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "Capecitabine" (9 trials), "Docetaxel" (8 trials), "Oxaliplatin" (7 trials) and "Enzalutamide" (5 trials). Other intervention names were less common.

The vast majority of trials in "Catharina Ziekenhuis" are 337 trials for "All" genders, 39 trials for "Female" genders and 24 trials for "Male" genders.

Currently, there are 143 active trials in "Catharina Ziekenhuis". 5 are not yet recruiting, 85 are recruiting, 47 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 180 completed trials in Catharina Ziekenhuis, 1 suspended trials, and 34 terminated clinical trials to date.

Out of the total trials that were conducted in Catharina Ziekenhuis, 6 "Phase 1" clinical trials were conducted, 46 "Phase 2" clinical trials and 96 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 31 trials, and there were also 134 trials that are defined as “Not Applicable".